Trials / Terminated
TerminatedNCT03209128
Cerebral Prophylactic Irradiation With Saving Hippocampus and Amygdala
Savings of Hippocampus and Amygdala by Archetherapy in Cerebral Prophylactic Irradiation in Patients With Limited and / or Extended, Responsive or Stable Small Cell Lung Cancer (SCLC)
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 11 (actual)
- Sponsor
- Centre Francois Baclesse, Luxembourg · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Hippocampus and amygdala are parts of the brain involved in the recognition of emotions, memories, memory, language ... It is therefore very important to protect them during irradiation of the brain. The aim of this study is to evaluate cerebral irradiation with saving hippocampus and amygdala protects these brain functions in patients with small cell lung cancer (SCLC) Radiotherapy of the brain
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | Irradiation prophyllactique cérébrale | Irradiation prophyllactique cérébrale |
Timeline
- Start date
- 2017-04-20
- Primary completion
- 2019-12-31
- Completion
- 2021-03-19
- First posted
- 2017-07-06
- Last updated
- 2022-06-23
Locations
1 site across 1 country: Luxembourg
Source: ClinicalTrials.gov record NCT03209128. Inclusion in this directory is not an endorsement.